Excited to share a new review from Endevica Bio examining melanocortin drug development to understand why a clinically validated target kept failing.
Key insight: past failures reflected limitations of the molecules tested—not the melanocortin system itself.
www.frontiersin.org/journals/end...
frontiersin.org
Frontiers | The melanocortin receptors as targets for general obesity: contextualizing clinical failures and analyzing future perspectives
The melanocortin system is a genetically conserved and clinically validated target for the treatment of obesity. Hundreds of studies establish the role of th...